Researchers find prostate cancer stem cell

	Tweet

Researchers have found a stem cell, a kind of master cell, that may cause at least some types of prostate cancer.

Their findings are only experimental—the stem cells were found in mice—but could explain at least some types of prostate cancer and eventually offer new ways to treat it, they reported on Wednesday in the journal Nature.

The findings also show a potential new source for prostate tumors—so-called luminal cells, which secrete various compounds used in the prostate.

"The role of stem cells in the development of prostate cancer has been a focus of speculation for many years,” Dr. Helen Rippon of Britain’s Prostate Cancer Charity said in a statement.

“Importantly, this new stem cell does not rely on androgens—the male sex hormones that control prostate growth—to survive and grow. This may give a clue as to why prostate cancer often becomes resistant to treatments designed to regulate these androgens in the later stages of the disease,” added Rippon, who was not involved in the research.

“This improved knowledge will also be a step forward in learning how we might help to prevent the disease from developing in men in the first place.”

Michael Shen of Columbia University Medical Center and colleagues named the new stem cells CARNs, for castration-resistant Nkx3.1-expressing cells.

They normally regenerate part of the tissue that lines the inside of the gland, which produces semen. But the cells can also form tumors if certain genes meant to stop out-of-control growth get turned off.

Shen said researchers had believed that tumors arise from a different layer of cells in the prostate, called basal cells.

“Previous research suggested that prostate cancer originates from basal stem cells, and that during cancer formation these cells differentiate into luminal cells,” Shen said in a statement. “Instead, CARNs may represent a luminal origin for prostate cancer.”

Prostate cancer is the second most common cancer in men worldwide after lung cancer, killing 254,000 men a year globally.

SOURCE: Nature, online September 9, 2009.

RELATED STORIES:
Cancer in sister affects black men’s cancer risk   Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues   Vitamin E may raise prostate cancer risk   First Biomarker Discovered that Predicts Prostate Cancer Outcome   Men Treated for Localized Prostate Cancer Could Benefit from Pomegranate Juice Consumption   Prostate cancer patients see high survival rates with seed implants   Common genetic prostate cancer variant identified   Radiation therapy technique reduces length of prostate cancer treatment   Advanced-Stage Prostate Cancer Patients Experience 20-Year Survival Rates With Surgery   PSA test alone not an ideal predictor of prostate cancer   Surgical Prospectives in High-Risk Prostate Cancer   Trapping prostate cancer cells to keep them from spreading provides hope   Closely monitoring low-risk prostate cancer, with biopsy, does not raise risk of death   Genetic and Behavioral Differences Add to Prostate Cancer Disparities   Cholesterol and cancer: Answers and some new questions   Sweeping View of Prostate Cancer Genome Yields Deep Insights   Study links acetaminophen to lower prostate cancer risk   Study links obesity to more agressive prostate cancer   Prostate cancer therapy linked to increased risk of heart disease death   Men Can Take Their Time to Decide on Prostate Cancer Treatment   Combination of genetic mutation and viral infection may cause prostate cancer   Selected Men with Low-Risk Prostate Cancer Have Good Clinical Outcomes without Immediate Treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]